8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2018 / Randomized controlled trial
Participants were randomly assigned to consume two kiwifruits per day for 5 months or no kiwifruit, with initial periodontal treatment (IPT) delivered at 2 months. At 2 months prior to IPT, bleeding score decreased significantly within the kiwifruit group by 6.67% ± 11.90% (P < 0.01), and the kiwifruit group had significantly lower values of bleeding, plaque, and attachment loss compared to controls. After IPT at 5 months, both groups demonstrated clinical benefits, but the control group had significantly greater reductions of bleeding, plaque, and attachment loss than the test group. Systemic biomarkers and vital signs showed no clinically relevant differences between groups.
Graziani F, Discepoli N, Gennai S, et al. J Periodontol, 2018. PMID 29520772
2011 / Free-living, self-controlled intervention study
In a free-living, self-controlled study, 24 subjects consumed 2 kiwifruits 1 hour before bedtime nightly for 4 weeks. Sleep parameters were evaluated using the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI), a 3-day sleep diary, and actigraphy. After 4 weeks, the subjective CPSQI score, waking time after sleep onset, and sleep onset latency decreased significantly by 42.4%, 28.9%, and 35.4%, respectively. Total sleep time and sleep efficiency significantly increased by 13.4% and 5.41%, respectively.
Lin HH, Tsai PS, Fang SC, et al. Asia Pac J Clin Nutr, 2011. PMID 21669584
2010 / Randomized controlled trial
In an 8-week clinical trial, 102 healthy male smokers were randomized to an antioxidant-rich diet, a diet supplemented with three kiwifruits daily, or a control group. Both dietary interventions significantly upregulated blood cell gene sets involved in cellular stress defense, including DNA repair, hypoxia, and apoptosis, relative to controls (FDR q < 0.05). Plasma antioxidant biomarkers also increased in both intervention arms.
Bøhn SK, Myhrstad MC, Thoresen M, et al. BMC Med, 2010. PMID 20846424
2001 / Human supplementation trial with ex vivo and in vitro testing
In a human supplementation trial, participants consumed a single 0.5-liter drink of kiwifruit juice or water as a control, and DNA damage was measured in isolated lymphocytes using the comet assay. Ex vivo, kiwifruit consumption increased DNA resistance to H2O2-induced oxidative damage compared with the water control, though no effect was observed on endogenous DNA damage. In vitro, a kiwifruit extract buffered to pH 7 provided greater protection against DNA damage than an equivalent vitamin C solution, although neither had a protective effect at the highest concentrations tested.
Collins BH, Horská A, Hotten PM, et al. Nutr Cancer, 2001. PMID 11588897